Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGM4G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,618
Award facts
- Contract value 100% obligated
- $21,618.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,618.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 6, 2026, for the supply of Dupixent 300 mg/2 ml pen injections with an ultimate completion date of January 7, 2026. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4), is a major pharmaceutical distributor providing brand-name and generic medications, vaccines, and specialized healthcare commodities to federal agencies. The company holds significant contracts with the Defense Logistics Agency and serves critical customers including the Defense Health Agency and U.S. Coast Guard. Dupixent (dupilumab) is a biologic treatment commonly prescribed for moderate-to-severe eczema, asthma, and other allergic conditions, representing part of AmerisourceBergen's extensive portfolio of specialty medications supplied to military treatment facilities and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FGM4G?
SPE2DR26FGM4G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FGM4G worth?
The government has obligated $21,618 on SPE2DR26FGM4G.
Is contract SPE2DR26FGM4G an order under another contract?
Yes. SPE2DR26FGM4G is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGM4G competed?
The extent of competition for SPE2DR26FGM4G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award